0000000000400751

AUTHOR

Wm Kremer

showing 7 related works from this author

Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis

2020

Background Diabetes mellitus may lead to increased serum ammonia and systemic inflammation thereby promoting hepatic encephalopathy (HE). Aim To investigate the potential association between diabetes mellitus/glycaemic control and the presence of covert HE as well as the development of overt HE in a prospective setting. Methods A total of 240 patients with liver cirrhosis were included into this prospective cohort study and followed for a median of 17 months. Covert HE was diagnosed by pathological results in the Portosystemic Hepatic Encephalopathy Score. Predictors for the presence of covert HE or the development of overt HE were analysed using logistic regression or Cox-regression models…

medicine.medical_specialtyCirrhosisHepatologybusiness.industryGastroenterologymedicine.diseaseLogistic regressionGastroenterologyInternal medicineDiabetes mellitusmedicinePharmacology (medical)Liver functionProspective cohort studybusinessComplicationPathologicalHepatic encephalopathyAlimentary Pharmacology & Therapeutics
researchProduct

Epidemiologie und Auswirkungen bakterieller Infektionen bei stationären Patienten mit Leberzirrhose

2020

Zeitschrift für Gastroenterologie
researchProduct

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis

2020

Introduction Frailty is a common but often underestimated complication in patients with liver cirrhosis. The Clinical Frailty Scale (CFS) allows the assessment of frailty within a short period of time but has only been investigated in a Canadian cohort of outpatients. The aim of the current study was to evaluate the ability of the CFS to predict mortality in outpatients and nonelectively hospitalized German patients. Methods Two hundred outpatients and 99 nonelectively hospitalized patients with liver cirrhosis were prospectively enrolled. Outpatients/inpatients were followed for a median of 364/28 days regarding the primary outcome of death or liver transplantation. Eighty-seven patients o…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosismedicine.medical_treatmentLiver transplantationMuscle massRisk AssessmentSeverity of Illness IndexArticle03 medical and health sciences0302 clinical medicineInternal medicineGermanymedicineHumansIn patientHospital MortalityProspective StudiesMuscle SkeletalAgedFrailtybusiness.industryHazard ratioGastroenterologyAcute-On-Chronic Liver FailureOdds ratioMiddle Agedmedicine.diseaseLiver TransplantationHospitalizationLiver030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologyFemaleComplicationbusinessTomography X-Ray ComputedFollow-Up StudiesClinical and Translational Gastroenterology
researchProduct

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outs…

2021

Background ADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous treatment for intensive care patients with liver failure. Data related to the applicability and safety as discontinuous treatment outside of ICU is not available. Aim Evaluation of ADVOS as discontinuous treatment for patients with ACLF outside intensive care unit and comparison with a matched historic cohort. Methods and results In this retrospective study, 26 patients with ACLF and the indication for renal replacement therapy related to HRS-AK…

MalePhysiologymedicine.medical_treatmentLiver transplantationToxicologyPathology and Laboratory MedicineSeverity of Illness IndexBiochemistrylaw.inventionBlood Urea Nitrogen0302 clinical medicinelawLiver Cirrhosis AlcoholicMedicine and Health SciencesMedicineBileMultidisciplinaryLiver DiseasesQRMiddle AgedIntensive care unitBody FluidsRenal Replacement TherapyLiverCirrhosisNephrologyCreatinineMedicine030211 gastroenterology & hepatologyFemaleHemodialysisAnatomyDetoxificationResearch Articlemedicine.medical_specialtyCritical CareScienceSurgical and Invasive Medical ProceduresGastroenterology and Hepatology03 medical and health sciencesDigestive System ProceduresRenal DialysisIntensive careInternal medicineAlbuminsMedical DialysisHumansRenal replacement therapyDialysisRetrospective StudiesTransplantationbusiness.industryAcute-On-Chronic Liver FailureBiology and Life SciencesProteins030208 emergency & critical care medicineRetrospective cohort studyBilirubinOrgan TransplantationSurvival AnalysisLiver TransplantationPatient ComplianceLiver functionbusinessBiomarkersPLoS ONE
researchProduct

Clinical Frailty Scale for Risk Stratification in Patients with Sars-Cov-2 Infection

2020

Predictive factors for adverse outcomes in patients with COVID-19 are urgently needed. Data related to the applicability of the Clinical Frailty Scale (CFS) for risk stratification in patients with COVID-19 are currently lacking. We investigated the ability of CFS to predict need for mechanical ventilation and the duration of hospital stays in European patients with COVID-19. In total, 42 patients with confirmed COVID-19 infection admitted to the University Medical Center Mainz between March 3 and April 15 2020 were included into this validation study and data were retrospectively analyzed. CFS was assessed at admission in all patients. Patients were followed for need for mechanical ventil…

Male2474medicine.medical_specialtyTime FactorsMultivariate analysisintensive care unitsmedicine.medical_treatmentPneumonia ViralRisk AssessmentSeverity of Illness IndexGeneral Biochemistry Genetics and Molecular BiologyBetacoronavirusGermanyInternal medicineSeverity of illnessHumansMedicineIn patientPandemicsAgedRetrospective StudiesMechanical ventilationRespiratory Distress SyndromeFrailtySARS-CoV-2business.industryProportional hazards modelBrief ReportAge FactorsCOVID-19Retrospective cohort studyGeneral MedicineLength of StayMiddle AgedRespiration ArtificialPatient DischargeMultivariate AnalysisRisk stratificationFemaleCoronavirus InfectionsRisk assessmentbusinessJournal of Investigative Medicine
researchProduct

Sarcopenia as prognostic factor for survival after orthotopic liver transplantation

2020

Background and aim Body composition has emerged as a prognostic factor for end-stage liver disease. We therefore investigated muscle mass, body fat and other clinical-pathological variables as predictors of posttransplant survival. Methods A total of 368 patients, who underwent orthotopic liver transplantation (OLT) at our institution, were assessed prior to OLT and followed for a median of 9.0 years (range 2.0-10.0 years) after OLT. Psoas, erector spinae and the combined paraspinal muscle area, as well as the corresponding indices normalized by body-height squared, were quantified by a lumbar (L3) cross-sectional computed tomography. In addition, absolute body fat and bone density were est…

AdultMaleSarcopeniamedicine.medical_specialtyBone densityUrologyEnd Stage Liver Disease03 medical and health sciencesLiver disease0302 clinical medicineLumbarErector spinae musclesHumansMedicineRetrospective StudiesAnatomy Cross-SectionalHepatologybusiness.industryHazard ratioGastroenterologyHepatitis CMiddle AgedPrognosismedicine.diseaseConfidence intervalLiver Transplantation030220 oncology & carcinogenesisSarcopeniaBody CompositionFemale030211 gastroenterology & hepatologyTomography X-Ray ComputedbusinessEuropean Journal of Gastroenterology & Hepatology
researchProduct

Symptom burden and treatment response in patients with primary biliary cholangitis (PBC) – real life data form Germany

2019

Treatment responsemedicine.medical_specialtybusiness.industryInternal medicineSymptom burdenMedicineIn patientbusinessReal life dataZeitschrift für Gastroenterologie
researchProduct